Sunday, September 14, 2014 10:55:49 AM
Doc 1 PDF file
http://www.scribd.com/doc/239707906/SEC-v-Spencer-Pharmaceutical-Inc-Et-Al-Doc-107-Filed-12-Sep-14
Doc 1-1 PDF file
http://www.scribd.com/doc/239707964/SEC-v-Spencer-Pharmaceutical-Inc-Et-Al-Doc-107-1-Filed-12-Sep-14
Doc 1-2 PDF file
http://www.scribd.com/doc/239708012/SEC-v-Spencer-Pharmaceutical-Inc-Et-Al-Doc-107-2-Filed-12-Sep-14
Doc 1-3 PDF file
http://www.scribd.com/doc/239708061/SEC-v-Spencer-Pharmaceutical-Inc-Et-Al-Doc-107-3-Filed-12-Sep-14
Doc 1-4 PDF file
http://www.scribd.com/doc/239708115/SEC-v-Spencer-Pharmaceutical-Inc-Et-Al-Doc-107-4-Filed-12-Sep-14
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM